by Sam Tetlow | Apr 16, 2024 | Funding Strategies, Non-Dilutive Funds
In our dynamic world of life sciences, the journey from innovative idea to market success is complex and challenging. Starting in the early 1940’s the KOL has become an instrumental and pivotal aspect to a viable go to market strategy. One crucial aspect of this...
by Sam Tetlow | Apr 9, 2024 | Uncategorized
In the intricate and competitive world of grant applications, the margin for error is often narrow. Review committees, study section chairs, lay-reviewers, and programmatic reviewers all act on the fundamental premise that securing grant funding is not merely about...
by Sam Tetlow | Mar 7, 2024 | Funding Strategies, Funding Your R&D, Uncategorized
In 2024, the National Institutes of Health (NIH) continues its mission to foster medical and behavioral research through its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Integral to these programs is the budget...
by Sam Tetlow | Mar 5, 2024 | Funding Strategies, Grantsmanship, Non-Dilutive Financing, Uncategorized
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs stand out as critical catalysts in the dynamic technological innovation landscape, encouraging small businesses to engage in research and development with commercial...
by Sam Tetlow | Feb 20, 2024 | Accounting & Reporting, Funding Strategies, Funding Your R&D, Grantsmanship
The Small Business Innovation Research (SBIR) program is essential for scientific and technological advancement, requiring meticulous financial management. Understanding the distinction between allowable and unallowable expenses under this program is crucial for...
Recent Comments